Noninvasive Prenatal Diagnostics Market Noninvasive Prenatal Diagnostics Market : ToC


Noninvasive Prenatal Diagnostics Market

Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and Others) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022

  • Rep Id : TMRGL374
  • Published On : May 2015
  • No. of Pages : 112
  • Category : Healthcare

 

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

      1.3.1 Assumptions

      1.3.2 Sources

              1.3.2.1 Secondary Research

              1.3.2.2 Primary Research

      1.3.3 Models

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Non-Invasive Prenatal Testing (NIPT) Market (2013 & 2022)

2.2 Global Non-Invasive Prenatal Testing Market, by Test, 2013 (USD Million)

2.3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2013 & 2022 (Value %)

2.4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2013 & 2022 (Volume %)

 

Chapter 3 Global Non-Invasive Prenatal Testing Market Overview

3.1 Introduction

3.2 Major Chromosomal Aneuploidies and their Incidence Rate

      3.2.1 Down Syndrome

      3.2.2 Edwards Syndrome

      3.2.3 Patau Syndrome

      3.2.4 Turner Syndrome

      3.2.5 Klinefelter Syndrome

      3.2.6 Jacobs Syndrome

      3.2.7 Triple X Syndrome

3.3 Technological Approach for NIPT

3.4 Patent Landscape

      3.4.1 Major Patents issued to Sequenom, Inc.

      3.4.2 Major Patents issued to Ariosa Diagnostics, Inc.

      3.4.3 Major Patents issued to Natera, Inc.

      3.4.4 Major Patents issued to Verinata Health, Inc. (Illumina, Inc.)

      3.4.5 Major Patents issued to Cellscape Corporation

      3.4.6 Others

3.5 Market Drivers

      3.5.1 High incidence rate of babies born with Down syndrome

      3.5.2 Globally rising average maternal age

      3.5.3 Increasing demand for early and non-invasive fetal testing procedures

3.6 Market Restraints

      3.6.1 Regulatory guidelines and ethical hurdles

      3.6.2 Limitations of NIPT

      3.6.3 Availability of other screening and testing methods

3.7 Market Opportunities

      3.7.1 Capitalizing on the potential presented by the emerging markets of Asia

3.8 Porter’s Five Force Analysis: Global Non-Invasive Prenatal testing Market

      3.8.1 Bargaining power of suppliers

      3.8.2 Bargaining power of buyers

      3.8.3 Threat of substitutes

      3.8.4 Threat of new entrants

      3.8.5 Competitive rivalry

3.9 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography

      3.9.1 Market Attractive Analysis: Global Non-Invasive Prenatal Testing Market, by Geography

3.10 Competitive Landscape

      3.10.1 Market Share Analysis, by Key Players, 2013 (%)

      3.10.2 Non-Invasive Prenatal Testing: Market Share, by Key Players, 2013(%)

 

Chapter 4 Global Non-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Test

4.1 Overview

      4.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 – 2022 (USD Million)

      4.1.2 Global Non-Invasive Prenatal Testing Market Volume, by Test, 2012 – 2022 (Number of Tests Performed)

      4.1.3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2013 & 2022 (Value %)

      4.1.4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Test, 2013 & 2022 (Volume %)

4.2 BambniTest

      4.2.1 Global BambniTest Test Market Revenue, 2012 – 2022 (USD Million)

      4.2.2 Global BambniTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.3 Harmony Prenatal Test

      4.3.1 Global Harmony Test Market Revenue, 2012 – 2022 (USD Million)

      4.3.2 Global Harmony Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.4 informaSeq Prenatal Test

      4.4.1 Global informaSeq Test Market Revenue, 2014 – 2022 (USD Million)

      4.4.2 Global informaSeq Test Market Volume, 2014 – 2022 (Number of Tests Performed)

4.5 MaterniT21 PLUS

      4.5.1 Global MaterniT21 PLUS Test Market Revenue, 2012 – 2022 (USD Million)

      4.5.2 Global MaterniT21 PLUS Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.6 Non-invasive Fetal Trisomy (NIFTY) Test

      4.6.1 Global NIFTY Test Market Revenue, 2012 – 2022 (USD Million)

      4.6.2 Global NIFTY Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.7 Panorama Test

      4.7.1 Global Panorama Test Market Revenue, 2012 – 2022 (USD Million)

      4.7.2 Global Panorama Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.8 PrenaTest

      4.8.1 Global PrenaTest Test Market Revenue, 2012 – 2022 (USD Million)

      4.8.2 Global PrenaTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.9 verifi

      4.9.1 Global verifi Test Market Revenue, 2012 – 2022 (USD Million)

      4.9.2 Global verifi Test Market Volume, 2012 – 2022 (Number of Tests Performed)

4.10 VisibiliT Test

      4.10.1 Global VisibiliT Test Market Revenue, 2014 – 2022 (USD Million)

      4.10.2 Global VisibiliT Test Market Volume, 2014 – 2022 (Number of Tests Performed)

4.11 Others

      4.11.1 Global Other Tests Market Revenue, 2014 – 2022 (USD Million)

      4.11.2 Global Other Tests Market Volume, 2014 – 2022 (Number of Tests Performed)

 

Chapter 5 Global Non-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Geography

5.1 Overview

      5.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 – 2022 (USD Million)

      5.1.2 Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2012 – 2022 (Number of Tests Performed)

5.2 North America

      5.2.1 North America Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.2.2 North America Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

5.3 Europe

      5.3.1 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.3.2 Europe Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

5.4 Asia-Pacific

      5.4.1 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.4.2 Asia-Pacific Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

5.5 Rest of the World (RoW)

      5.5.1 RoW Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

      5.5.2 RoW Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

 

Chapter 6 Recommendations

6.1 Focus on improving technology in order to increase the accuracy, reduce the duration of result generation and price

6.2 Focus on forming alliances with diagnostic service providers in Latin American and Asia-Pacific countries

6.3 Mergers and acquisitions

 

Chapter 7 Company Profiles

7.1 Ariosa Diagnostics, Inc.

      7.1.1 Company Overview

      7.1.2 Financial Overview

      7.1.3 Product Portfolio

      7.1.4 Business Strategies

      7.1.5 Recent Developments

7.2 Berry Genomics Co., Ltd.

      7.2.1 Company Overview

      7.2.2 Financial Overview

      7.2.3 Product Portfolio

      7.2.4 Business Strategies

      7.2.5 Recent Developments

7.3 BGI Diagnostics

      7.3.1 Company Overview

      7.3.2 Financial Overview

      7.3.3 Product Portfolio

      7.3.4 Business Strategies

      7.3.5 Recent Developments

7.4 Illumina, Inc.

      7.4.1 Company Overview

      7.4.2 Financial Overview

      7.4.3 Product Portfolio

      7.4.4 Business Strategies

      7.4.5 Recent Developments

7.5 Laboratory Corporation of America Holdings (LabCorp)

      7.5.1 Company Overview

      7.5.2 Financial Overview

      7.5.3 Product Portfolio

      7.5.4 Business Strategies

      7.5.5 Recent Developments

7.6 LifeCodexx AG

      7.6.1 Company Overview

      7.6.2 Financial Overview

      7.6.3 Product Portfolio

      7.6.4 Business Strategies

      7.6.5 Recent Developments

7.7 Natera, Inc.

      7.7.1 Company Overview

      7.7.2 Financial Overview

      7.7.3 Product Portfolio

      7.7.4 Business Strategies

      7.7.5 Recent Developments

7.8 Sequenom, Inc.

      7.8.1 Company Overview

      7.8.2 Financial Overview

      7.8.3 Product Portfolio

      7.8.4 Business Strategies

      7.8.5 Recent Developments

List of Tables

 

TABLE 1 Market Snapshot: Global Non-Invasive Prenatal Testing (NIPT) Market (2013 & 2022)

TABLE 2 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 – 2022 (USD Million)

TABLE 3 Global Non-Invasive Prenatal Testing Market Volume, by Test, 2012 – 2022 (Number of Tests Performed)

TABLE 4 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 – 2022 (USD Million)

TABLE 5 Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2012 – 2022 (Number of Tests Performed)

TABLE 6 Ariosa Diagnostics, Inc.: Expenses & Revenue, 2011 – 2013 (USD Thousand)

TABLE 7 Sequenom, Inc.: Expenses & Revenue, 2011 – 2013 (USD Million)

List of Figures

 

FIG. 1 Non-Invasive Prenatal Testing: Market Segmentation

FIG. 2 Global Non-Invasive Prenatal Testing Market, by Test, 2013 (USD Million)

FIG. 3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2013 & 2022 (Value %)

FIG. 4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2013 & 2022 (Volume %)

FIG. 5 Porter’s Five Force Analysis: Global Non-Invasive Prenatal Testing Market

FIG. 6 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography

FIG. 7 Non-Invasive Prenatal Testing: Market Share, by Key Players, 2013 (%)

FIG. 8 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2013 & 2022 (Value %)

FIG. 9 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Test, 2013 & 2022 (Volume %)

FIG. 10 Global BambniTest Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 11 Global BambniTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 12 Global Harmony Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 13 Global Harmony Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 14 Global informaSeq Test Market Revenue, 2014 – 2022 (USD Million)

FIG. 15 Global informaSeq Test Market Volume, 2014 – 2022 (Number of Tests Performed)

FIG. 16 Global MaterniT21 PLUS Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 17 Global MaterniT21 PLUS Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 18 Global NIFTY Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 19 Global NIFTY Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 20 Global Panorama Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 21 Global Panorama Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 22 Global PrenaTest Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 23 Global PrenaTest Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 24 Global verifi Test Market Revenue, 2012 – 2022 (USD Million)

FIG. 25 Global verifi Test Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 26 Global VisibiliT Test Market Revenue, 2014 – 2022 (USD Million)

FIG. 27 Global VisibiliT Test Market Volume, 2014 – 2022 (Number of Tests Performed)

FIG. 28 Global Other Tests Market Revenue, 2014 – 2022 (USD Million)

FIG. 29 Global Other Tests Market Volume, 2014 – 2022 (Number of Tests Performed)

FIG. 30 North America Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022     (USD Million)

FIG. 31 North America Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 32 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 33 Europe Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 34 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 35 Asia-Pacific Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 36 RoW Non-Invasive Prenatal Testing Market Revenue, 2012 – 2022 (USD Million)

FIG. 37 RoW Non-Invasive Prenatal Testing Market Volume, 2012 – 2022 (Number of Tests Performed)

FIG. 38 LabCorp: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 39 Sequenom, Inc.: Annual Revenue, by Segment, 2011 – 2013 (USD Million)

.